Rupture of uterus in the first trimester during medical termination of pregnancy for exomphalos using mifepristone/misoprostol.
Willmott
F J
FJ
Department of Obstetrics and Gynaecology, University Hospital of Wales, Cardiff, UK. willmottfj@hotmail.co.uk
Scherf
C
C
Ford
S M
SM
Lim
K
K
D015746:Abdominal Pain / Q000139:chemically induced; D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000032:Abortion, Therapeutic / Q000009:adverse effects*; D000282:Administration, Intravaginal; D000284:Administration, Oral; D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D005315:Fetal Diseases / Q000000981:diagnostic imaging; D006554:Hernia, Umbilical / Q000000981:diagnostic imaging / Q000196:embryology; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D016595:Misoprostol / Q000009:adverse effects*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D014463:Ultrasonography; D014597:Uterine Rupture / Q000139:chemically induced*
D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol; D015735:Mifepristone